Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
Makras, P., Polyzos S. A., Anastasilakis A. D., Terpos E., Papatheodorou A., & Kaltsas G. A. (2012).  Is serum IL-17A a useful systemic biomarker in patients with Langerhans cell histiocytosis?. Mol Ther. 20(1), 6-7.
Makras, P., Appelman-Dijkstra N. M., Papapoulos S. E., van Wissen S., Winter E. M., Polyzos S. A., et al. (2021).  The duration of denosumab treatment and the efficacy of zoledronate to preserve bone mineral density after its discontinuation.. J Clin Endocrinol Metab.
Makri, E. S., Makri E., & Polyzos S. A. (2022).  Combination Therapies for Nonalcoholic Fatty Liver Disease.. J Pers Med. 12(7), 
Makri, E., Goulas A., & Polyzos S. A. (2021).  Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease.. Arch Med Res. 52(1), 25-37.
Makri, E., & Tziomalos K. (2017).  Prevalence, etiology and management of non-alcoholic fatty liver disease in patients with polycystic ovary syndrome.. Minerva Endocrinol. 42(2), 122-131.
Makri, E. S., Xanthopoulos K., Parasidis P. Mavrommati, Makri E., Pettas S., Tsingotjidou A., et al. (2024).  Partial validation of a six-month high-fat diet and fructose-glucose drink combination as a mouse model of nonalcoholic fatty liver disease.. Endocrine.
Makri, E. S., Goulas A., & Polyzos S. A. (2021).  Sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease.. Eur J Pharmacol. 907, 174272.
Makri, E., Kita M., Goulas A., Papaioannidou P., Efstathiadou Z. A., Adamidou F., et al. (2020).  Comparative effectiveness of glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors on noninvasive indices of hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus.. Diabetes Metab Syndr. 14(6), 1913-1919.
Makri, E., Cholongitas E., & Tziomalos K. (2016).  Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease.. World J Gastroenterol. 22(41), 9039-9043.
Makri, E. S., Evripidou K., & Polyzos S. A. (2024).  Circulating leptin in patients with nonalcoholic fatty liver disease-related liver fibrosis: a systematic review and a meta-analysis.. J Gastroenterol Hepatol.
Makri, E., Orfanidou M., Makri E. S., Goulas A., Terpos E., & Polyzos S. A. (2024).  Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.. J Clin Exp Hepatol. 14(3), 101353.
Makris, V., Papavasiliou K. A., Bobos M., Hytiroglou P., Kirkos J. M., & Kapetanos G. A. (2009).  [Simultaneous existence of unicameral bone cysts involving the femur and ischium].. Acta Orthop Traumatol Turc. 43(2), 185-9.
Makris, V., Daniilidis A., Koiou A., Balaouras D., Fotinakis I., Spathopoulou S., et al. (2015).  Microparticles hyperactivity in a case of intrauterine growth restriction.. Clin Exp Obstet Gynecol. 42(2), 231-3.
Makrydimas, G., Barmpalia Z., & Sotiriadis A. (2019).  Cervical cerclage for women with shortening cervix while on progesterone.. Am J Obstet Gynecol. 220(2), 209-210.
Makrydimas, G., & Sotiriadis A. (2014).  Prediction of preterm birth in twins.. Best Pract Res Clin Obstet Gynaecol. 28(2), 265-72.
Maladaki, A., Yavropoulou M. P., Kotsa K., Tranga T., Ventis S., & Yovos J. G. (2012).  Non tumoral hyperserotoninaemia responsive to octreotide due to dual polymorphism in UGT1A1 and UGT1A6.. Hormones (Athens). 11(1), 104-8.
Malamas, A., Chranioti A., Tsakalidis C., Dimitrakos S. A., & Mataftsi A. (2017).  The omega-3 and retinopathy of prematurity relationship.. Int J Ophthalmol. 10(2), 300-305.
Malamas, A., Dervenis N., Kilintzis V., Chranioti A., & Topouzis F. (2019).  Inter- and intraobserver repeatability and reproducibility of choroidal thickness measurements using two different methods.. Int Ophthalmol. 39(5), 1061-1069.
Malandris, K., Papandreou S., Avgerinos I., Karagiannis T., Paschos P., Michailidis T., et al. (2023).  Comparative efficacy of glucose-lowering drugs on liver steatosis as assessed by means of magnetic resonance imaging in patients with type 2 diabetes mellitus: systematic review and network meta-analysis.. Hormones (Athens). 22(4), 655-664.
Maletic, J., Tsirka V., Ioannides P., Karacostas D., & Taskos N. (2010).  Parry-Romberg Syndrome Associated with Localized Scleroderma.. Case Rep Neurol. 2(2), 57-62.
Malhotra, K., Katsanos A. H., Goyal N., Ahmed N., Strbian D., Palaiodimou L., et al. (2020).  Safety and efficacy of dual antiplatelet pretreatment in patients with ischemic stroke treated with IV thrombolysis: A systematic review and meta-analysis.. Neurology. 94(7), e657-e666.
Malindretos, P., Liaskos C., Bamidis P., Chryssogonidis I., Lasaridis A., & Nikolaidis P. (2014).  Computer assisted sound analysis of arteriovenous fistula in hemodialysis patients.. Int J Artif Organs. 37(2), 173-6.
Malindretos, P., Sarafidis P., Spaia S., Sioulis A., Zeggos N., Raptis V., et al. (2010).  Adaptation and validation of the Kidney Disease Quality of Life-Short Form questionnaire in the Greek language.. Am J Nephrol. 31(1), 9-14.
Malindretos, P. M., Sarafidis P. A., Geropoulou E. Z., Kapoulas S., Paramythiotis D. D., & Lasaridis A. N. (2008).  Sustained hypotension complicating an extra-adrenal pheochromocytoma.. Am J Hypertens. 21(7), 840-2.
Malindretos, P., Sarafidis P., Lazaridis A., & Nikolaidis P. (2012).  A study of the association of higher parathormone levels with health-related quality of life in hemodialysis patients.. Clin Nephrol. 77(3), 196-203.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.